Navigation Links
GBC Seeks Nominations for Region's Third Annual Bioscience Awards

BALTIMORE, Jan. 14 /PRNewswire-USNewswire/ -- The Greater Baltimore Committee is seeking nominations for the Third Annual Greater Baltimore Region Bioscience Awards to be held on Tuesday, March 18, 2008. Those interested in nominating a company or individual for an award, visit

The four award categories are: Entrepreneurial, Best New Product or Progress, Leadership in Bioscience, and President's Award. Nominators will be asked to submit documentation and narratives that fulfill several criteria and then to add other supporting evidence as deemed suitable. Self-nominations are accepted and encouraged. Nominations will close on March 10, 2008.

"We want to make sure that the researcher with a marketable idea, the mid-sized medical device company and all in the region's bioscience industry know that we appreciate the contribution they are making to our economy," said Donald C. Fry, President and CEO of the Greater Baltimore Committee.

Judges for the awards are: Ravinder Dhallan, M.D./Ph.D., M.B.A., chairman and chief executive officer, Ravgen; Steve Dubin, chief executive officer, Martek Biosciences Corporation; Aaron H. Heifetz, Ph.D., vice president business development, Cognate BioServices, Inc.; James Hughes, vice president research and development, University of Maryland, Baltimore; Shira Kramer, Ph.D., president, Sterilex Corporation; and Mark E. Rapson, CPA, shareholder and leader, Health & Life Science Group, KAWG&F.

Program sponsor for the event is KAWG&F. Media sponsor is The Daily Record.

For more information, contact Lisbeth Pettengill at the Greater Baltimore Committee, 410-727-2820 or email to

SOURCE Greater Baltimore Committee
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Pharsight Announces Fiscal Third Quarter 2008 Earnings Release Date and Conference Call
2. Pharsight Signs Third WinNonlin(R) AutoPilot(TM) Customer
3. Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
4. Genoptix Reports Strong Financial Results For Third Quarter 2007
5. International Human Rights Day Recognized by Terasem Movement, Inc.s Third Annual Colloquium on the Law of Transbeman Persons
6. Reminder: Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
7. Carrington Reports Third Quarter 2007 Results
8. Shamir Optical Industry Ltd. Reports Third Quarter 2007 Results
9. China Kangtai Cactus Biotech, Inc. Reports Third Quarter 2007 Financial Results
10. China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results
11. Healthcare Technologies Reports 2007 Nine Months & Third Quarter Results
Post Your Comments:
(Date:11/24/2015)... SAN DIEGO , Nov. 24, 2015 Halozyme Therapeutics, ... Jaffray Healthcare Conference in New York on ... Dr. Helen Torley , president and CEO, will provide a ... New York at 1:00 p.m. ET/10:00 a.m. ... communication and investor relations, will provide a corporate overview. --> ...
(Date:11/24/2015)... Mass. (PRWEB) , ... November 24, 2015 , ... ... to maintain healthy metabolism. But unless it is bound to proteins, copper is ... of Health (NIH), researchers at Worcester Polytechnic Institute (WPI) will conduct a systematic ...
(Date:11/24/2015)... - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the "Company"), ... Toronto Stock Exchange, confirms that as of the date ... that would cause the recent movements in the Company,s ... About Aeterna Zentaris Inc. . ... Zentaris is a specialty biopharmaceutical company engaged in developing ...
(Date:11/24/2015)... 24, 2015 --> ... report "Oligonucleotide Synthesis Market by Product & Services (Primer, ... Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic ... the market is expected to reach USD 1,918.6 Million ... a CAGR of 10.1% during the forecast period. ...
Breaking Biology Technology:
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... BOSTON , Oct. 29, 2015  Connected health ... phenomena driving the explosion of technology-enabled health and wellness, ... his new book, The Internet of Healthy ... apps, sensors or smartphones even existed, Dr. Kvedar, vice ... model of health care delivery, moving care from the ...
(Date:10/27/2015)... , Oct. 27, 2015 Synaptics Inc. (NASDAQ: ... today announced that Google has adopted the Synaptics ® ... controller solutions to power its newest flagship smartphones, the ... Huawei. --> --> ... Google to provide strategic collaboration in the joint development ...
Breaking Biology News(10 mins):